SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?


To: Anthony Wong who wrote (4049)7/8/1998 6:33:00 PM
From: Barron Von Hymen  Read Replies (2) | Respond to of 9523
 
Oh poor Vivus, I'm crying a river for you - not. Earnings should be good for PFE.



To: Anthony Wong who wrote (4049)7/8/1998 7:04:00 PM
From: Anthony Wong  Respond to of 9523
 
Help! The Viagra police are after me

by Mark Hughes-Morgan

Ian Pont believes he is the first victim of the so-called "V-Men" - the task
force set up last week by the Medicines Control Agency to clamp down
on the unlicensed supply of Viagra, the anti-impotence "wonder drug".

A former professional cricketer - pace bowler for Essex and
Nottinghamshire - Pont runs a mail-order herbal medicine company,
Sunlife Health, from his home in Wickford, Essex. He recently started to
market a remedy called Yohimbe Plus.

A blend of bark, ginseng and amino acids, its blurb was effusive. "Tried
and tested Yohimbe," it read, "the bark from an African tree, is
considered to be one of the most effective natural aphrodisiacs."

Pont says: "In Africa they brew the bark in tea. Millions use this product
in America, you can buy it over the counter. It's completely safe."

But then along came Viagra - and Pont seized the opportunity to
capitalise on the extraordinary interest in the drug. He began promoting
his herbal alternative as "Nature's Answer to Viagra" - and his troubles
began.

A few days ago, Pont and his wife returned from holiday to find two
investigators from the Medicines Control Agency outside their house. "It
was 8.30pm and there were two of them, a man and woman, standing on
the doorstep," says Pont. "They said they had a warrant. We had had no
warning, no letter, nothing. But, even though it was not convenient, we let
them in."

The two investigators handed the Ponts a letter which accused them of
supplying a drug, "yohimbine bark", which "is restricted under current
legislation ... and therefore can only be supplied from a registered
pharmacy or hospital". It went on: "You are required to cease all
marketing and sales of Yohimbine Plus immediately."

Pont was mystified. "There is no such thing as 'yohimbine bark'. It's
yohimbine or yohimbe bark. How could it be banned?

"I believe there is pressure from the drugs companies to stop people
capitalising on all the interest [in Viagra]."

The MCA denies this categorically, and pointed out to Pont that yohimbe
bark "is restricted in the United Kingdom by Part 1 of the Schedule to the
Medicines Order 1977/2130 and can only be supplied by a registered
pharmacy or hospital."

Pont believes there has been a confusion. "There is a synthesized drug
based on yohimbe," he says. "It is called yohimbine hydrochloride, but it
has a totally different molecular structure to Yohimbe Plus."

Yohimbe works by increasing blood flow to the genitals. The effective
ingredient, yohimbine, is an alkaloid, which seems to reduce the effect of
some hormones that cause constriction of the blood vessels to the penis.
These hormones increase as men get older.

Dr Richard Petty, Medical Director of the Wellman Clinic in central
London, has imported a synthesized version from Switzerland for his own
patients "over a number of years", and reports mixed results.

"It works for some people but not for others, so I don't use it much now.
There is a low success rate, but medical journals indicate that for people
for whom it worked, it worked very well. It wasn't a placebo effect. So I
still have a few patients who are happy to take it."

He was very surprised to learn that you could buy the bark in the UK,
and that the MCA has tried to stop its sale. "America is just as particular
as we are, if not more so, about what they allow the public to do and I'm
sure they would have done something about this if it had been particularly
dangerous." He does, however, admit that there is always a risk of people
taking excessive doses, particularly with substances used for sex.

According to Judith Atkin, a pharmaceuticals broker who represents
Phillips Nutritionals, manufacturer of Yohimbe Plus: "There's nothing to
stop you ordering it outside the country by credit card. It's freely available
on the Internet and in Europe. That is what is so daft about the rules in
this country."

Which is no help for Ian Pont, who was given seven days to comply with
the order to stop selling Yohimbe Plus. "It is quite ridiculous that a
product used safely by millions throughout the world is banned in Britain,
when the alternative, Viagra, has already been behind several deaths."

c Associated Newspapers Ltd., 07 July 1998
This Is London



To: Anthony Wong who wrote (4049)7/8/1998 7:41:00 PM
From: BDR  Read Replies (1) | Respond to of 9523
 
<<Vivus claims that its drug has fallen victim to the advertising frenzy
attached to Viagra>>

What advertising frenzy? Vivus refuses to recognize that they have a much less desirable product and continue to place the blame on someone or something else.